Need professional-grade analysis? Visit stockanalysis.com
$1.62B
21.74
970
N/A
ANI Pharmaceuticals Inc (ANIP) trades on United States in USD. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at $80.92, up 3.65% from the previous close.
Over the past year, ANIP has traded between a low of $57.27 and a high of $98.81. The stock has gained 17.4% over this period. It is currently 18.1% below its 52-week high.
ANI Pharmaceuticals Inc has a market capitalization of $1.62B, with a price-to-earnings ratio of 21.74.
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Side-by-side comparison against top Healthcare peers.